Advertisement

Index by author

May 01, 2003; Volume 31,Issue 5

A

  1. Agrawal, Arun K.

    1. Constitutive and Inducible Hepatic Cytochrome P450 Isoforms in Senescent Male and Female Rats and Response to Low-Dose Phenobarbital
      Arun K. Agrawal and Bernard H. Shapiro
      Drug Metabolism and Disposition May 2003, 31 (5) 612-619; DOI: https://doi.org/10.1124/dmd.31.5.612

  2. Akiyama, Taro E.

    1. Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam
      Camille P. Granvil, Ai-Ming Yu, Guillermo Elizondo, Taro E. Akiyama, Connie Cheung, Lionel Feigenbaum, Kristopher W. Krausz and Frank J. Gonzalez
      Drug Metabolism and Disposition May 2003, 31 (5) 548-558; DOI: https://doi.org/10.1124/dmd.31.5.548

  3. Ando, Masanori

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  4. André, Jean-Claude

    1. Toxicokinetics and Metabolism ofN-[14C]N-Methyl-2-Pyrrolidone in Male Sprague-Dawley Rats: in Vivo and in Vitro Percutaneous Absorption
      Jean-Paul Payan, Isabelle Boudry, Dominique Beydon, Jean-Paul Fabry, Marie-Christine Grandclaude, Elisabeth Ferrari and Jean-Claude André
      Drug Metabolism and Disposition May 2003, 31 (5) 659-669; DOI: https://doi.org/10.1124/dmd.31.5.659

  5. Aono, Hironao

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

B

  1. Bandiera, Stelvio M.

    1. Response to Letter to the Editor
      Thomas K. H. Chang, Stelvio M. Bandiera and Jie Chen
      Drug Metabolism and Disposition May 2003, 31 (5) 686; DOI: https://doi.org/10.1124/dmd.31.5.686

  2. Bélanger, Alain

    1. Glucuronidation Activity of the UGT2B17 Enzyme toward Xenobiotics
      David Turgeon, Jean-Sébastien Carrier, Sarah Chouinard and Alain Bélanger
      Drug Metabolism and Disposition May 2003, 31 (5) 670-676; DOI: https://doi.org/10.1124/dmd.31.5.670

  3. Beydon, Dominique

    1. Toxicokinetics and Metabolism ofN-[14C]N-Methyl-2-Pyrrolidone in Male Sprague-Dawley Rats: in Vivo and in Vitro Percutaneous Absorption
      Jean-Paul Payan, Isabelle Boudry, Dominique Beydon, Jean-Paul Fabry, Marie-Christine Grandclaude, Elisabeth Ferrari and Jean-Claude André
      Drug Metabolism and Disposition May 2003, 31 (5) 659-669; DOI: https://doi.org/10.1124/dmd.31.5.659

  4. Borbás, Tı́mea

    1. Identification of Metabolic Pathways Involved in the Biotransformation of Tolperisone by Human Microsomal Enzymes
      Balázs Dalmadi, János Leibinger, Szabolcs Szeberényi, Tı́mea Borbás, Sándor Farkas, Zsolt Szombathelyi and Károly Tihanyi
      Drug Metabolism and Disposition May 2003, 31 (5) 631-636; DOI: https://doi.org/10.1124/dmd.31.5.631

  5. Boudry, Isabelle

    1. Toxicokinetics and Metabolism ofN-[14C]N-Methyl-2-Pyrrolidone in Male Sprague-Dawley Rats: in Vivo and in Vitro Percutaneous Absorption
      Jean-Paul Payan, Isabelle Boudry, Dominique Beydon, Jean-Paul Fabry, Marie-Christine Grandclaude, Elisabeth Ferrari and Jean-Claude André
      Drug Metabolism and Disposition May 2003, 31 (5) 659-669; DOI: https://doi.org/10.1124/dmd.31.5.659

  6. Breau, Alan P.

    1. Involvement of Human UGT2B7 and 2B15 in Rofecoxib Metabolism
      Ji Y. Zhang, Jenny Zhan, Chyung S. Cook, Robert M. Ings and Alan P. Breau
      Drug Metabolism and Disposition May 2003, 31 (5) 652-658; DOI: https://doi.org/10.1124/dmd.31.5.652

  7. Buckley, Arthur R.

    1. Induction of Cytochrome P450 3A by Paclitaxel in Mice: Pivotal Role of the Nuclear Xenobiotic Receptor, Pregnane X Receptor
      Srikanth C. Nallani, Bryan Goodwin, Jodi M. Maglich, Donna J. Buckley, Arthur R. Buckley and Pankaj B. Desai
      Drug Metabolism and Disposition May 2003, 31 (5) 681-684; DOI: https://doi.org/10.1124/dmd.31.5.681

  8. Buckley, Donna J.

    1. Induction of Cytochrome P450 3A by Paclitaxel in Mice: Pivotal Role of the Nuclear Xenobiotic Receptor, Pregnane X Receptor
      Srikanth C. Nallani, Bryan Goodwin, Jodi M. Maglich, Donna J. Buckley, Arthur R. Buckley and Pankaj B. Desai
      Drug Metabolism and Disposition May 2003, 31 (5) 681-684; DOI: https://doi.org/10.1124/dmd.31.5.681

  9. Buist, Susan C. N.

    1. Endocrine Regulation of Rat Organic Anion Transporters
      Susan C. N. Buist, Nathan J. Cherrington and Curtis D. Klaassen
      Drug Metabolism and Disposition May 2003, 31 (5) 559-564; DOI: https://doi.org/10.1124/dmd.31.5.559

C

  1. Carol, Kathleen M.

    1. Regulation of Drug Transporter Gene Expression by Nuclear Receptors
      Jeff L. Staudinger, Ajay Madan, Kathleen M. Carol and Andrew Parkinson
      Drug Metabolism and Disposition May 2003, 31 (5) 523-527; DOI: https://doi.org/10.1124/dmd.31.5.523

  2. Carrier, Jean-Sébastien

    1. Glucuronidation Activity of the UGT2B17 Enzyme toward Xenobiotics
      David Turgeon, Jean-Sébastien Carrier, Sarah Chouinard and Alain Bélanger
      Drug Metabolism and Disposition May 2003, 31 (5) 670-676; DOI: https://doi.org/10.1124/dmd.31.5.670

  3. Chang, Thomas K. H.

    1. Response to Letter to the Editor
      Thomas K. H. Chang, Stelvio M. Bandiera and Jie Chen
      Drug Metabolism and Disposition May 2003, 31 (5) 686; DOI: https://doi.org/10.1124/dmd.31.5.686

  4. Chavin, Kenneth D.

    1. Siberian Ginseng (Eleutheroccus senticosus) Effects on CYP2D6 and CYP3A4 Activity in Normal Volunteers
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Robin M. Taylor and John S. Markowitz
      Drug Metabolism and Disposition May 2003, 31 (5) 519-522; DOI: https://doi.org/10.1124/dmd.31.5.519

  5. Chen, Guangping

    1. Tamoxifen Induction of Aryl Sulfotransferase and Hydroxysteroid Sulfotransferase in Male and Female Rat Liver and Intestine
      Smarajit Maiti and Guangping Chen
      Drug Metabolism and Disposition May 2003, 31 (5) 637-644; DOI: https://doi.org/10.1124/dmd.31.5.637

  6. Chen, Jie

    1. Response to Letter to the Editor
      Thomas K. H. Chang, Stelvio M. Bandiera and Jie Chen
      Drug Metabolism and Disposition May 2003, 31 (5) 686; DOI: https://doi.org/10.1124/dmd.31.5.686

  7. Cherrington, Nathan J.

    1. Endocrine Regulation of Rat Organic Anion Transporters
      Susan C. N. Buist, Nathan J. Cherrington and Curtis D. Klaassen
      Drug Metabolism and Disposition May 2003, 31 (5) 559-564; DOI: https://doi.org/10.1124/dmd.31.5.559

  8. Cheung, Connie

    1. Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam
      Camille P. Granvil, Ai-Ming Yu, Guillermo Elizondo, Taro E. Akiyama, Connie Cheung, Lionel Feigenbaum, Kristopher W. Krausz and Frank J. Gonzalez
      Drug Metabolism and Disposition May 2003, 31 (5) 548-558; DOI: https://doi.org/10.1124/dmd.31.5.548

  9. Chouinard, Sarah

    1. Glucuronidation Activity of the UGT2B17 Enzyme toward Xenobiotics
      David Turgeon, Jean-Sébastien Carrier, Sarah Chouinard and Alain Bélanger
      Drug Metabolism and Disposition May 2003, 31 (5) 670-676; DOI: https://doi.org/10.1124/dmd.31.5.670

  10. Clement, Bernd

    1. Characterization of in Vitro Biotransformation of New, Orally Active, Direct Thrombin Inhibitor Ximelagatran, an Amidoxime and Ester Prodrug
      Bernd Clement and Katrin Lopian
      Drug Metabolism and Disposition May 2003, 31 (5) 645-651; DOI: https://doi.org/10.1124/dmd.31.5.645

  11. Cook, Chyung S.

    1. Involvement of Human UGT2B7 and 2B15 in Rofecoxib Metabolism
      Ji Y. Zhang, Jenny Zhan, Chyung S. Cook, Robert M. Ings and Alan P. Breau
      Drug Metabolism and Disposition May 2003, 31 (5) 652-658; DOI: https://doi.org/10.1124/dmd.31.5.652

  12. Court, Michael H.

    1. Quantitation of CYP2B6, Constitutive Androstane Receptor, and Pregnane X Receptor mRNA levels
      Leah M. Hesse and Michael H. Court
      Drug Metabolism and Disposition May 2003, 31 (5) 685; DOI: https://doi.org/10.1124/dmd.31.5.685

D

  1. Dalmadi, Balázs

    1. Identification of Metabolic Pathways Involved in the Biotransformation of Tolperisone by Human Microsomal Enzymes
      Balázs Dalmadi, János Leibinger, Szabolcs Szeberényi, Tı́mea Borbás, Sándor Farkas, Zsolt Szombathelyi and Károly Tihanyi
      Drug Metabolism and Disposition May 2003, 31 (5) 631-636; DOI: https://doi.org/10.1124/dmd.31.5.631

  2. Desai, Pankaj B.

    1. Induction of Cytochrome P450 3A by Paclitaxel in Mice: Pivotal Role of the Nuclear Xenobiotic Receptor, Pregnane X Receptor
      Srikanth C. Nallani, Bryan Goodwin, Jodi M. Maglich, Donna J. Buckley, Arthur R. Buckley and Pankaj B. Desai
      Drug Metabolism and Disposition May 2003, 31 (5) 681-684; DOI: https://doi.org/10.1124/dmd.31.5.681

  3. DeVane, C. Lindsay

    1. Siberian Ginseng (Eleutheroccus senticosus) Effects on CYP2D6 and CYP3A4 Activity in Normal Volunteers
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Robin M. Taylor and John S. Markowitz
      Drug Metabolism and Disposition May 2003, 31 (5) 519-522; DOI: https://doi.org/10.1124/dmd.31.5.519

  4. Donovan, Jennifer L.

    1. Siberian Ginseng (Eleutheroccus senticosus) Effects on CYP2D6 and CYP3A4 Activity in Normal Volunteers
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Robin M. Taylor and John S. Markowitz
      Drug Metabolism and Disposition May 2003, 31 (5) 519-522; DOI: https://doi.org/10.1124/dmd.31.5.519

E

  1. Elizondo, Guillermo

    1. Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam
      Camille P. Granvil, Ai-Ming Yu, Guillermo Elizondo, Taro E. Akiyama, Connie Cheung, Lionel Feigenbaum, Kristopher W. Krausz and Frank J. Gonzalez
      Drug Metabolism and Disposition May 2003, 31 (5) 548-558; DOI: https://doi.org/10.1124/dmd.31.5.548

F

  1. Fabry, Jean-Paul

    1. Toxicokinetics and Metabolism ofN-[14C]N-Methyl-2-Pyrrolidone in Male Sprague-Dawley Rats: in Vivo and in Vitro Percutaneous Absorption
      Jean-Paul Payan, Isabelle Boudry, Dominique Beydon, Jean-Paul Fabry, Marie-Christine Grandclaude, Elisabeth Ferrari and Jean-Claude André
      Drug Metabolism and Disposition May 2003, 31 (5) 659-669; DOI: https://doi.org/10.1124/dmd.31.5.659

  2. Fahmi, Odette A.

    1. Influence of Lipophilicity on the Interactions ofN-Alkyl-4-phenyl-1,2,3,6-tetrahydropyridines and Their Positively Charged N-Alkyl-4-phenylpyridinium Metabolites with Cytochrome P450 2D6
      Amit S. Kalgutkar, Sue Zhou, Odette A. Fahmi and Timothy J. Taylor
      Drug Metabolism and Disposition May 2003, 31 (5) 596-605; DOI: https://doi.org/10.1124/dmd.31.5.596

  3. Farkas, Sándor

    1. Identification of Metabolic Pathways Involved in the Biotransformation of Tolperisone by Human Microsomal Enzymes
      Balázs Dalmadi, János Leibinger, Szabolcs Szeberényi, Tı́mea Borbás, Sándor Farkas, Zsolt Szombathelyi and Károly Tihanyi
      Drug Metabolism and Disposition May 2003, 31 (5) 631-636; DOI: https://doi.org/10.1124/dmd.31.5.631

  4. Faucette, Stephanie R.

    1. Glucocorticoid Receptor Enhancement of Pregnane X Receptor-Mediated CYP2B6 Regulation in Primary Human Hepatocytes
      Hongbing Wang, Stephanie R. Faucette, Darryl Gilbert, Summer L. Jolley, Tatsuya Sueyoshi, Masahiko Negishi and Edward L. LeCluyse
      Drug Metabolism and Disposition May 2003, 31 (5) 620-630; DOI: https://doi.org/10.1124/dmd.31.5.620

  5. Feigenbaum, Lionel

    1. Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam
      Camille P. Granvil, Ai-Ming Yu, Guillermo Elizondo, Taro E. Akiyama, Connie Cheung, Lionel Feigenbaum, Kristopher W. Krausz and Frank J. Gonzalez
      Drug Metabolism and Disposition May 2003, 31 (5) 548-558; DOI: https://doi.org/10.1124/dmd.31.5.548

  6. Ferrari, Elisabeth

    1. Toxicokinetics and Metabolism ofN-[14C]N-Methyl-2-Pyrrolidone in Male Sprague-Dawley Rats: in Vivo and in Vitro Percutaneous Absorption
      Jean-Paul Payan, Isabelle Boudry, Dominique Beydon, Jean-Paul Fabry, Marie-Christine Grandclaude, Elisabeth Ferrari and Jean-Claude André
      Drug Metabolism and Disposition May 2003, 31 (5) 659-669; DOI: https://doi.org/10.1124/dmd.31.5.659

G

  1. Gilbert, Darryl

    1. Glucocorticoid Receptor Enhancement of Pregnane X Receptor-Mediated CYP2B6 Regulation in Primary Human Hepatocytes
      Hongbing Wang, Stephanie R. Faucette, Darryl Gilbert, Summer L. Jolley, Tatsuya Sueyoshi, Masahiko Negishi and Edward L. LeCluyse
      Drug Metabolism and Disposition May 2003, 31 (5) 620-630; DOI: https://doi.org/10.1124/dmd.31.5.620

  2. Gonzalez, Frank J.

    1. Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam
      Camille P. Granvil, Ai-Ming Yu, Guillermo Elizondo, Taro E. Akiyama, Connie Cheung, Lionel Feigenbaum, Kristopher W. Krausz and Frank J. Gonzalez
      Drug Metabolism and Disposition May 2003, 31 (5) 548-558; DOI: https://doi.org/10.1124/dmd.31.5.548

  3. Goodwin, Bryan

    1. Induction of Cytochrome P450 3A by Paclitaxel in Mice: Pivotal Role of the Nuclear Xenobiotic Receptor, Pregnane X Receptor
      Srikanth C. Nallani, Bryan Goodwin, Jodi M. Maglich, Donna J. Buckley, Arthur R. Buckley and Pankaj B. Desai
      Drug Metabolism and Disposition May 2003, 31 (5) 681-684; DOI: https://doi.org/10.1124/dmd.31.5.681

  4. Grandclaude, Marie-Christine

    1. Toxicokinetics and Metabolism ofN-[14C]N-Methyl-2-Pyrrolidone in Male Sprague-Dawley Rats: in Vivo and in Vitro Percutaneous Absorption
      Jean-Paul Payan, Isabelle Boudry, Dominique Beydon, Jean-Paul Fabry, Marie-Christine Grandclaude, Elisabeth Ferrari and Jean-Claude André
      Drug Metabolism and Disposition May 2003, 31 (5) 659-669; DOI: https://doi.org/10.1124/dmd.31.5.659

  5. Granvil, Camille P.

    1. Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam
      Camille P. Granvil, Ai-Ming Yu, Guillermo Elizondo, Taro E. Akiyama, Connie Cheung, Lionel Feigenbaum, Kristopher W. Krausz and Frank J. Gonzalez
      Drug Metabolism and Disposition May 2003, 31 (5) 548-558; DOI: https://doi.org/10.1124/dmd.31.5.548

H

  1. Halpert, James R.

    1. Editorial
      James R. Halpert
      Drug Metabolism and Disposition May 2003, 31 (5) 509; DOI: https://doi.org/10.1124/dmd.31.5.509

  2. Hanioka, Nobumitsu

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  3. Hesse, Leah M.

    1. Quantitation of CYP2B6, Constitutive Androstane Receptor, and Pregnane X Receptor mRNA levels
      Leah M. Hesse and Michael H. Court
      Drug Metabolism and Disposition May 2003, 31 (5) 685; DOI: https://doi.org/10.1124/dmd.31.5.685

  4. Higuchi, Shun

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  5. Hirota, Takeshi

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  6. Hyland, R.

    1. Identification of the Cytochrome P450 Enzymes Involved in the N-Oxidation of Voriconazole
      R. Hyland, B. C. Jones and D. A. Smith
      Drug Metabolism and Disposition May 2003, 31 (5) 540-547; DOI: https://doi.org/10.1124/dmd.31.5.540

I

  1. Ieiri, Ichiro

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  2. Ings, Robert M.

    1. Involvement of Human UGT2B7 and 2B15 in Rofecoxib Metabolism
      Ji Y. Zhang, Jenny Zhan, Chyung S. Cook, Robert M. Ings and Alan P. Breau
      Drug Metabolism and Disposition May 2003, 31 (5) 652-658; DOI: https://doi.org/10.1124/dmd.31.5.652

J

  1. Jinno, Hideto

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  2. Jolley, Summer L.

    1. Glucocorticoid Receptor Enhancement of Pregnane X Receptor-Mediated CYP2B6 Regulation in Primary Human Hepatocytes
      Hongbing Wang, Stephanie R. Faucette, Darryl Gilbert, Summer L. Jolley, Tatsuya Sueyoshi, Masahiko Negishi and Edward L. LeCluyse
      Drug Metabolism and Disposition May 2003, 31 (5) 620-630; DOI: https://doi.org/10.1124/dmd.31.5.620

  3. Jones, B. C.

    1. Identification of the Cytochrome P450 Enzymes Involved in the N-Oxidation of Voriconazole
      R. Hyland, B. C. Jones and D. A. Smith
      Drug Metabolism and Disposition May 2003, 31 (5) 540-547; DOI: https://doi.org/10.1124/dmd.31.5.540

  4. Jusko, William J.

    1. Diversity of Mechanism-Based Pharmacodynamic Models
      Donald E. Mager, Elzbieta Wyska and William J. Jusko
      Drug Metabolism and Disposition May 2003, 31 (5) 510-518; DOI: https://doi.org/10.1124/dmd.31.5.510

K

  1. Kagayama, Akira

    1. Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro
      Yoichi Naritomi, Shigeyuki Terashita, Akira Kagayama and Yuichi Sugiyama
      Drug Metabolism and Disposition May 2003, 31 (5) 580-588; DOI: https://doi.org/10.1124/dmd.31.5.580

  2. Kalgutkar, Amit S.

    1. Influence of Lipophilicity on the Interactions ofN-Alkyl-4-phenyl-1,2,3,6-tetrahydropyridines and Their Positively Charged N-Alkyl-4-phenylpyridinium Metabolites with Cytochrome P450 2D6
      Amit S. Kalgutkar, Sue Zhou, Odette A. Fahmi and Timothy J. Taylor
      Drug Metabolism and Disposition May 2003, 31 (5) 596-605; DOI: https://doi.org/10.1124/dmd.31.5.596

  3. Kawamoto, Katsuyuki

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  4. Kharasch, Evan D.

    1. Comparison of In Vitro and In Vivo Inhibition Potencies of Fluvoxamine toward CYP2C19
      Caiping Yao, Kent L. Kunze, William F. Trager, Evan D. Kharasch and René H. Levy
      Drug Metabolism and Disposition May 2003, 31 (5) 565-571; DOI: https://doi.org/10.1124/dmd.31.5.565

  5. Klaassen, Curtis D.

    1. Endocrine Regulation of Rat Organic Anion Transporters
      Susan C. N. Buist, Nathan J. Cherrington and Curtis D. Klaassen
      Drug Metabolism and Disposition May 2003, 31 (5) 559-564; DOI: https://doi.org/10.1124/dmd.31.5.559

  6. Krausz, Kristopher W.

    1. Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam
      Camille P. Granvil, Ai-Ming Yu, Guillermo Elizondo, Taro E. Akiyama, Connie Cheung, Lionel Feigenbaum, Kristopher W. Krausz and Frank J. Gonzalez
      Drug Metabolism and Disposition May 2003, 31 (5) 548-558; DOI: https://doi.org/10.1124/dmd.31.5.548

  7. Kume, Toshiyuki

    1. Glucuronidation of Etoposide in Human Liver Microsomes Is Specifically Catalyzed by UDP-Glucuronosyltransferase 1A1
      Yuichiro Watanabe, Miki Nakajima, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition May 2003, 31 (5) 589-595; DOI: https://doi.org/10.1124/dmd.31.5.589

  8. Kunze, Kent L.

    1. Comparison of In Vitro and In Vivo Inhibition Potencies of Fluvoxamine toward CYP2C19
      Caiping Yao, Kent L. Kunze, William F. Trager, Evan D. Kharasch and René H. Levy
      Drug Metabolism and Disposition May 2003, 31 (5) 565-571; DOI: https://doi.org/10.1124/dmd.31.5.565

L

  1. LeCluyse, Edward L.

    1. Glucocorticoid Receptor Enhancement of Pregnane X Receptor-Mediated CYP2B6 Regulation in Primary Human Hepatocytes
      Hongbing Wang, Stephanie R. Faucette, Darryl Gilbert, Summer L. Jolley, Tatsuya Sueyoshi, Masahiko Negishi and Edward L. LeCluyse
      Drug Metabolism and Disposition May 2003, 31 (5) 620-630; DOI: https://doi.org/10.1124/dmd.31.5.620

  2. Leibinger, János

    1. Identification of Metabolic Pathways Involved in the Biotransformation of Tolperisone by Human Microsomal Enzymes
      Balázs Dalmadi, János Leibinger, Szabolcs Szeberényi, Tı́mea Borbás, Sándor Farkas, Zsolt Szombathelyi and Károly Tihanyi
      Drug Metabolism and Disposition May 2003, 31 (5) 631-636; DOI: https://doi.org/10.1124/dmd.31.5.631

  3. Levy, René H.

    1. Comparison of In Vitro and In Vivo Inhibition Potencies of Fluvoxamine toward CYP2C19
      Caiping Yao, Kent L. Kunze, William F. Trager, Evan D. Kharasch and René H. Levy
      Drug Metabolism and Disposition May 2003, 31 (5) 565-571; DOI: https://doi.org/10.1124/dmd.31.5.565

  4. Lopian, Katrin

    1. Characterization of in Vitro Biotransformation of New, Orally Active, Direct Thrombin Inhibitor Ximelagatran, an Amidoxime and Ester Prodrug
      Bernd Clement and Katrin Lopian
      Drug Metabolism and Disposition May 2003, 31 (5) 645-651; DOI: https://doi.org/10.1124/dmd.31.5.645

  5. Lu, Hong

    1. Enzymology of Methylation of Tea Catechins and Inhibition of Catechol-O-methyltransferase by (−)-Epigallocatechin Gallate
      Hong Lu, Xiaofeng Meng and Chung S. Yang
      Drug Metabolism and Disposition May 2003, 31 (5) 572-579; DOI: https://doi.org/10.1124/dmd.31.5.572

M

  1. Madan, Ajay

    1. Regulation of Drug Transporter Gene Expression by Nuclear Receptors
      Jeff L. Staudinger, Ajay Madan, Kathleen M. Carol and Andrew Parkinson
      Drug Metabolism and Disposition May 2003, 31 (5) 523-527; DOI: https://doi.org/10.1124/dmd.31.5.523

  2. Mager, Donald E.

    1. Diversity of Mechanism-Based Pharmacodynamic Models
      Donald E. Mager, Elzbieta Wyska and William J. Jusko
      Drug Metabolism and Disposition May 2003, 31 (5) 510-518; DOI: https://doi.org/10.1124/dmd.31.5.510

  3. Maglich, Jodi M.

    1. Induction of Cytochrome P450 3A by Paclitaxel in Mice: Pivotal Role of the Nuclear Xenobiotic Receptor, Pregnane X Receptor
      Srikanth C. Nallani, Bryan Goodwin, Jodi M. Maglich, Donna J. Buckley, Arthur R. Buckley and Pankaj B. Desai
      Drug Metabolism and Disposition May 2003, 31 (5) 681-684; DOI: https://doi.org/10.1124/dmd.31.5.681

  4. Maiti, Smarajit

    1. Tamoxifen Induction of Aryl Sulfotransferase and Hydroxysteroid Sulfotransferase in Male and Female Rat Liver and Intestine
      Smarajit Maiti and Guangping Chen
      Drug Metabolism and Disposition May 2003, 31 (5) 637-644; DOI: https://doi.org/10.1124/dmd.31.5.637

  5. Margolis, Jeannine M.

    1. Impact of Nonspecific Binding to Microsomes and Phospholipid on the Inhibition of Cytochrome P4502D6: Implications for Relating in Vitro Inhibition Data to in Vivo Drug Interactions
      Jeannine M. Margolis and R. Scott Obach
      Drug Metabolism and Disposition May 2003, 31 (5) 606-611; DOI: https://doi.org/10.1124/dmd.31.5.606

  6. Markowitz, John S.

    1. Siberian Ginseng (Eleutheroccus senticosus) Effects on CYP2D6 and CYP3A4 Activity in Normal Volunteers
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Robin M. Taylor and John S. Markowitz
      Drug Metabolism and Disposition May 2003, 31 (5) 519-522; DOI: https://doi.org/10.1124/dmd.31.5.519

  7. Masada, Mikio

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  8. Meng, Xiaofeng

    1. Enzymology of Methylation of Tea Catechins and Inhibition of Catechol-O-methyltransferase by (−)-Epigallocatechin Gallate
      Hong Lu, Xiaofeng Meng and Chung S. Yang
      Drug Metabolism and Disposition May 2003, 31 (5) 572-579; DOI: https://doi.org/10.1124/dmd.31.5.572

  9. Minami, Hironobu

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

N

  1. Nakajima, Miki

    1. Glucuronidation of Etoposide in Human Liver Microsomes Is Specifically Catalyzed by UDP-Glucuronosyltransferase 1A1
      Yuichiro Watanabe, Miki Nakajima, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition May 2003, 31 (5) 589-595; DOI: https://doi.org/10.1124/dmd.31.5.589

  2. Nallani, Srikanth C.

    1. Induction of Cytochrome P450 3A by Paclitaxel in Mice: Pivotal Role of the Nuclear Xenobiotic Receptor, Pregnane X Receptor
      Srikanth C. Nallani, Bryan Goodwin, Jodi M. Maglich, Donna J. Buckley, Arthur R. Buckley and Pankaj B. Desai
      Drug Metabolism and Disposition May 2003, 31 (5) 681-684; DOI: https://doi.org/10.1124/dmd.31.5.681

  3. Naritomi, Yoichi

    1. Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro
      Yoichi Naritomi, Shigeyuki Terashita, Akira Kagayama and Yuichi Sugiyama
      Drug Metabolism and Disposition May 2003, 31 (5) 580-588; DOI: https://doi.org/10.1124/dmd.31.5.580

  4. Negishi, Masahiko

    1. Glucocorticoid Receptor Enhancement of Pregnane X Receptor-Mediated CYP2B6 Regulation in Primary Human Hepatocytes
      Hongbing Wang, Stephanie R. Faucette, Darryl Gilbert, Summer L. Jolley, Tatsuya Sueyoshi, Masahiko Negishi and Edward L. LeCluyse
      Drug Metabolism and Disposition May 2003, 31 (5) 620-630; DOI: https://doi.org/10.1124/dmd.31.5.620

O

  1. Obach, R. Scott

    1. Impact of Nonspecific Binding to Microsomes and Phospholipid on the Inhibition of Cytochrome P4502D6: Implications for Relating in Vitro Inhibition Data to in Vivo Drug Interactions
      Jeannine M. Margolis and R. Scott Obach
      Drug Metabolism and Disposition May 2003, 31 (5) 606-611; DOI: https://doi.org/10.1124/dmd.31.5.606

  2. Ohashi, Noriko

    1. Glucuronidation of Etoposide in Human Liver Microsomes Is Specifically Catalyzed by UDP-Glucuronosyltransferase 1A1
      Yuichiro Watanabe, Miki Nakajima, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition May 2003, 31 (5) 589-595; DOI: https://doi.org/10.1124/dmd.31.5.589

  3. Ohtsu, Atsushi

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  4. Otsubo, Kenji

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  5. Ozawa, Shogo

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

P

  1. Parkinson, Andrew

    1. Regulation of Drug Transporter Gene Expression by Nuclear Receptors
      Jeff L. Staudinger, Ajay Madan, Kathleen M. Carol and Andrew Parkinson
      Drug Metabolism and Disposition May 2003, 31 (5) 523-527; DOI: https://doi.org/10.1124/dmd.31.5.523

  2. Payan, Jean-Paul

    1. Toxicokinetics and Metabolism ofN-[14C]N-Methyl-2-Pyrrolidone in Male Sprague-Dawley Rats: in Vivo and in Vitro Percutaneous Absorption
      Jean-Paul Payan, Isabelle Boudry, Dominique Beydon, Jean-Paul Fabry, Marie-Christine Grandclaude, Elisabeth Ferrari and Jean-Claude André
      Drug Metabolism and Disposition May 2003, 31 (5) 659-669; DOI: https://doi.org/10.1124/dmd.31.5.659

R

  1. Raucy, Judy L.

    1. Regulation of CYP3A4 Expression in Human Hepatocytes by Pharmaceuticals and Natural Products
      Judy L. Raucy
      Drug Metabolism and Disposition May 2003, 31 (5) 533-539; DOI: https://doi.org/10.1124/dmd.31.5.533

S

  1. Saeki, Mayumi

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  2. Saijo, Nagahiro

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  3. Saito, Yoshiro

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  4. Sano, Hiroyuki

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  5. Sawada, Jun-ichi

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  6. Shapiro, Bernard H.

    1. Constitutive and Inducible Hepatic Cytochrome P450 Isoforms in Senescent Male and Female Rats and Response to Low-Dose Phenobarbital
      Arun K. Agrawal and Bernard H. Shapiro
      Drug Metabolism and Disposition May 2003, 31 (5) 612-619; DOI: https://doi.org/10.1124/dmd.31.5.612

  7. Shimizu, Eiji

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  8. Shirao, Kuniaki

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  9. Smith, D. A.

    1. Identification of the Cytochrome P450 Enzymes Involved in the N-Oxidation of Voriconazole
      R. Hyland, B. C. Jones and D. A. Smith
      Drug Metabolism and Disposition May 2003, 31 (5) 540-547; DOI: https://doi.org/10.1124/dmd.31.5.540

  10. Staudinger, Jeff L.

    1. Regulation of Drug Transporter Gene Expression by Nuclear Receptors
      Jeff L. Staudinger, Ajay Madan, Kathleen M. Carol and Andrew Parkinson
      Drug Metabolism and Disposition May 2003, 31 (5) 523-527; DOI: https://doi.org/10.1124/dmd.31.5.523

  11. Sueyoshi, Tatsuya

    1. Glucocorticoid Receptor Enhancement of Pregnane X Receptor-Mediated CYP2B6 Regulation in Primary Human Hepatocytes
      Hongbing Wang, Stephanie R. Faucette, Darryl Gilbert, Summer L. Jolley, Tatsuya Sueyoshi, Masahiko Negishi and Edward L. LeCluyse
      Drug Metabolism and Disposition May 2003, 31 (5) 620-630; DOI: https://doi.org/10.1124/dmd.31.5.620

  12. Sugiyama, Yuichi

    1. Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro
      Yoichi Naritomi, Shigeyuki Terashita, Akira Kagayama and Yuichi Sugiyama
      Drug Metabolism and Disposition May 2003, 31 (5) 580-588; DOI: https://doi.org/10.1124/dmd.31.5.580

  13. Szeberényi, Szabolcs

    1. Identification of Metabolic Pathways Involved in the Biotransformation of Tolperisone by Human Microsomal Enzymes
      Balázs Dalmadi, János Leibinger, Szabolcs Szeberényi, Tı́mea Borbás, Sándor Farkas, Zsolt Szombathelyi and Károly Tihanyi
      Drug Metabolism and Disposition May 2003, 31 (5) 631-636; DOI: https://doi.org/10.1124/dmd.31.5.631

  14. Szombathelyi, Zsolt

    1. Identification of Metabolic Pathways Involved in the Biotransformation of Tolperisone by Human Microsomal Enzymes
      Balázs Dalmadi, János Leibinger, Szabolcs Szeberényi, Tı́mea Borbás, Sándor Farkas, Zsolt Szombathelyi and Károly Tihanyi
      Drug Metabolism and Disposition May 2003, 31 (5) 631-636; DOI: https://doi.org/10.1124/dmd.31.5.631

T

  1. Takane, Hiroshi

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  2. Takeuchi, Hiromi

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  3. Tanaka-Kagawa, Toshiko

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  4. Taylor, Robin M.

    1. Siberian Ginseng (Eleutheroccus senticosus) Effects on CYP2D6 and CYP3A4 Activity in Normal Volunteers
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Robin M. Taylor and John S. Markowitz
      Drug Metabolism and Disposition May 2003, 31 (5) 519-522; DOI: https://doi.org/10.1124/dmd.31.5.519

  5. Taylor, Timothy J.

    1. Influence of Lipophilicity on the Interactions ofN-Alkyl-4-phenyl-1,2,3,6-tetrahydropyridines and Their Positively Charged N-Alkyl-4-phenylpyridinium Metabolites with Cytochrome P450 2D6
      Amit S. Kalgutkar, Sue Zhou, Odette A. Fahmi and Timothy J. Taylor
      Drug Metabolism and Disposition May 2003, 31 (5) 596-605; DOI: https://doi.org/10.1124/dmd.31.5.596

  6. Terashita, Shigeyuki

    1. Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro
      Yoichi Naritomi, Shigeyuki Terashita, Akira Kagayama and Yuichi Sugiyama
      Drug Metabolism and Disposition May 2003, 31 (5) 580-588; DOI: https://doi.org/10.1124/dmd.31.5.580

  7. Tihanyi, Károly

    1. Identification of Metabolic Pathways Involved in the Biotransformation of Tolperisone by Human Microsomal Enzymes
      Balázs Dalmadi, János Leibinger, Szabolcs Szeberényi, Tı́mea Borbás, Sándor Farkas, Zsolt Szombathelyi and Károly Tihanyi
      Drug Metabolism and Disposition May 2003, 31 (5) 631-636; DOI: https://doi.org/10.1124/dmd.31.5.631

  8. Trager, William F.

    1. Comparison of In Vitro and In Vivo Inhibition Potencies of Fluvoxamine toward CYP2C19
      Caiping Yao, Kent L. Kunze, William F. Trager, Evan D. Kharasch and René H. Levy
      Drug Metabolism and Disposition May 2003, 31 (5) 565-571; DOI: https://doi.org/10.1124/dmd.31.5.565

  9. Turgeon, David

    1. Glucuronidation Activity of the UGT2B17 Enzyme toward Xenobiotics
      David Turgeon, Jean-Sébastien Carrier, Sarah Chouinard and Alain Bélanger
      Drug Metabolism and Disposition May 2003, 31 (5) 670-676; DOI: https://doi.org/10.1124/dmd.31.5.670

W

  1. Wang, Hongbing

    1. Glucocorticoid Receptor Enhancement of Pregnane X Receptor-Mediated CYP2B6 Regulation in Primary Human Hepatocytes
      Hongbing Wang, Stephanie R. Faucette, Darryl Gilbert, Summer L. Jolley, Tatsuya Sueyoshi, Masahiko Negishi and Edward L. LeCluyse
      Drug Metabolism and Disposition May 2003, 31 (5) 620-630; DOI: https://doi.org/10.1124/dmd.31.5.620

  2. Watanabe, Yuichiro

    1. Glucuronidation of Etoposide in Human Liver Microsomes Is Specifically Catalyzed by UDP-Glucuronosyltransferase 1A1
      Yuichiro Watanabe, Miki Nakajima, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition May 2003, 31 (5) 589-595; DOI: https://doi.org/10.1124/dmd.31.5.589

  3. Wyska, Elzbieta

    1. Diversity of Mechanism-Based Pharmacodynamic Models
      Donald E. Mager, Elzbieta Wyska and William J. Jusko
      Drug Metabolism and Disposition May 2003, 31 (5) 510-518; DOI: https://doi.org/10.1124/dmd.31.5.510

Y

  1. Yamasaki, Akira

    1. Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
      Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, Katsuyuki Kawamoto, Hironao Aono, Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi and Kenji Otsubo
      Drug Metabolism and Disposition May 2003, 31 (5) 677-680; DOI: https://doi.org/10.1124/dmd.31.5.677

  2. Yang, Chung S.

    1. Enzymology of Methylation of Tea Catechins and Inhibition of Catechol-O-methyltransferase by (−)-Epigallocatechin Gallate
      Hong Lu, Xiaofeng Meng and Chung S. Yang
      Drug Metabolism and Disposition May 2003, 31 (5) 572-579; DOI: https://doi.org/10.1124/dmd.31.5.572

  3. Yao, Caiping

    1. Comparison of In Vitro and In Vivo Inhibition Potencies of Fluvoxamine toward CYP2C19
      Caiping Yao, Kent L. Kunze, William F. Trager, Evan D. Kharasch and René H. Levy
      Drug Metabolism and Disposition May 2003, 31 (5) 565-571; DOI: https://doi.org/10.1124/dmd.31.5.565

  4. Yokoi, Tsuyoshi

    1. Glucuronidation of Etoposide in Human Liver Microsomes Is Specifically Catalyzed by UDP-Glucuronosyltransferase 1A1
      Yuichiro Watanabe, Miki Nakajima, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition May 2003, 31 (5) 589-595; DOI: https://doi.org/10.1124/dmd.31.5.589

  5. Yoshida, Teruhiko

    1. Functional Characterization of Wild-type and Variant (T202I and M59I) Human UDP-glucuronosyltransferase 1A10
      Hideto Jinno, Mayumi Saeki, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Yoshiro Saito, Shogo Ozawa, Masanori Ando, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo and Jun-ichi Sawada
      Drug Metabolism and Disposition May 2003, 31 (5) 528-532; DOI: https://doi.org/10.1124/dmd.31.5.528

  6. Yu, Ai-Ming

    1. Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam
      Camille P. Granvil, Ai-Ming Yu, Guillermo Elizondo, Taro E. Akiyama, Connie Cheung, Lionel Feigenbaum, Kristopher W. Krausz and Frank J. Gonzalez
      Drug Metabolism and Disposition May 2003, 31 (5) 548-558; DOI: https://doi.org/10.1124/dmd.31.5.548

Z

  1. Zhan, Jenny

    1. Involvement of Human UGT2B7 and 2B15 in Rofecoxib Metabolism
      Ji Y. Zhang, Jenny Zhan, Chyung S. Cook, Robert M. Ings and Alan P. Breau
      Drug Metabolism and Disposition May 2003, 31 (5) 652-658; DOI: https://doi.org/10.1124/dmd.31.5.652

  2. Zhang, Ji Y.

    1. Involvement of Human UGT2B7 and 2B15 in Rofecoxib Metabolism
      Ji Y. Zhang, Jenny Zhan, Chyung S. Cook, Robert M. Ings and Alan P. Breau
      Drug Metabolism and Disposition May 2003, 31 (5) 652-658; DOI: https://doi.org/10.1124/dmd.31.5.652

  3. Zhou, Sue

    1. Influence of Lipophilicity on the Interactions ofN-Alkyl-4-phenyl-1,2,3,6-tetrahydropyridines and Their Positively Charged N-Alkyl-4-phenylpyridinium Metabolites with Cytochrome P450 2D6
      Amit S. Kalgutkar, Sue Zhou, Odette A. Fahmi and Timothy J. Taylor
      Drug Metabolism and Disposition May 2003, 31 (5) 596-605; DOI: https://doi.org/10.1124/dmd.31.5.596
Back to top

In this issue